1
|
Saunt JV, M Kelley K, Hileman CO, L Hussey D, Avery AK. Addressing HIV and Substance Use Health Disparities among Racial/Ethnic Minority Individuals. Curr HIV/AIDS Rep 2025; 22:29. [PMID: 40183964 PMCID: PMC11971190 DOI: 10.1007/s11904-025-00738-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/24/2025] [Indexed: 04/05/2025]
Abstract
PURPOSE OF REVIEW Advances in HIV testing, prevention, and treatment, alongside increased awareness and harm reduction efforts for substance use disorder (SUD) have improved care and treatment access over the past decade. However, racial and ethnic minorities with SUD and HIV or at risk for HIV still face disproportionately high health disparities. Understanding and addressing the reasons behind these disparities is crucial. RECENT FINDINGS Structural and systemic barriers continue to negatively impact minoritized communities, due to lack of access to care, mistrust, and feelings of ostracization. Disconnected systems for HIV and SUD treatment complicate combined care. Delays in HIV diagnosis and viral suppression reduce life expectancy for minority populations by around 10 years. Healthcare systems need to become more integrated, accessible, and culturally welcoming to marginalized communities. Promising interventions utilizing technology, harm reduction, and mobile service delivery can reduce barriers and improve outcomes for minority individuals.
Collapse
Affiliation(s)
- Jamie V Saunt
- Mandel School of Applied Social Sciences, Case Western Reserve University, Cleveland, OH, USA
| | - Kate M Kelley
- Department of Psychiatry, Center for Addiction Medicine, MetroHealth Medical Center, Cleveland, OH, USA
- School of Medicine, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, 44109, USA
| | - Corrilynn O Hileman
- Department of Medicine, Division of Infectious Diseases, MetroHealth Medical Center, Cleveland, OH, USA
- School of Medicine, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, 44109, USA
| | - David L Hussey
- Mandel School of Applied Social Sciences, Case Western Reserve University, Cleveland, OH, USA
| | - Ann K Avery
- Department of Medicine, Division of Infectious Diseases, MetroHealth Medical Center, Cleveland, OH, USA.
- School of Medicine, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, 44109, USA.
| |
Collapse
|
2
|
Nigro SE, Wu M, Juliano AC, Napier TC, Landay AL, French AL, Yang S. Impaired verbal memory in individuals living with HIV and cocaine dependence. J Clin Exp Neuropsychol 2022; 44:134-145. [PMID: 35786160 DOI: 10.1080/13803395.2022.2086219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
INTRODUCTION Our study aimed to understand the independent and combined effects of cocaine dependence and HIV status across aspects of verbal memory. METHOD Our sample consisted of a total of 102 individuals: 28 individuals living with HIV and cocaine dependence (HIV+/CD), 28 individuals who are HIV-negative with cocaine dependence (HIV-/CD), 20 individuals living with HIV without cocaine dependence (HIV+/ND), and 26 individuals who are HIV-negative without cocaine dependence (HIV-/ND). We utilized the Hopkins Verbal Learning Test-Revised Version (HVLT-R) to assess components of verbal memory, including encoding, recall, and recognition. A 2 (HIV: Yes/No) × 2 (Cocaine: Yes/No) MANCOVA on Total and Delayed Recall while controlling for premorbid intelligence was conducted. We used a Kruskal-Wallis H test to examine retrieval and recognition. RESULTS The combination of HIV and cocaine dependence amplified deficits on Total Recall. We found comparably poor performance across Delayed Recall between all three clinical groups. People living with HIV without cocaine dependence demonstrated intact recognition, whereas those with cocaine dependence had poor recognition. CONCLUSIONS HIV and cocaine both impacted verbal memory. However, there are potential subtle differences in the role cocaine versus HIV has on the memory process. People living with HIV without cocaine dependence recognized significantly more words than they could freely recall. In contrast, cocaine dependence impacted recognition in HIV and non-HIV groups. These performance patterns suggest HIV may be associated with retrieval deficits, whereas cocaine dependence may be associated with encoding deficits. Further research assessing these specific components of the memory process will help clarify these potential differences.
Collapse
Affiliation(s)
- Sarah E Nigro
- Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA
| | - Minjie Wu
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
| | - Anthony C Juliano
- Department of Psychiatry, University of Vermont, Burlington, VT, USA
| | - T Celeste Napier
- Department of Psychiatry & Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Alan L Landay
- Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA
| | - Audrey L French
- Department of Medicine, CORE Center/Stroger Hospital of Cook County, Chicago, IL, USA
| | - Shaolin Yang
- Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.,Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
| |
Collapse
|
3
|
Wilson EC, Hernandez CJ, Arayasirikul S, Scheer S, Trujillo D, Sicro S, Turner CM, McFarland W. In Their Own Words: How Trans Women Acquired HIV Infection. AIDS Behav 2022; 26:2091-2098. [PMID: 35031891 DOI: 10.1007/s10461-021-03555-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/06/2021] [Indexed: 11/01/2022]
Abstract
Despite high HIV prevalence, the reasons trans women acquire HIV are not well understood. Trans women are often mis-classified or aggregated with men who have sex with men (MSM) in epidemiologic studies and HIV surveillance data. Trans women enrolled in the 2019/2020 National HIV Behavioral Surveillance Study in San Francisco were asked an open-ended question about how they were infected with HIV. The most common responses were "Sex with a straight cisgender man partner when the respondent identified as a trans woman" (43.0%); "Sexual assault" (13.9%); "Injection drug use (IDU)" (10.1%); "IDU or sexual contact" (7.6%) and "Sex with a partner who injected drugs" (7.6%). Sex with a cisgender man partner prior to identifying as a trans women (MSM contact) was not mentioned by any respondent. HIV prevention strategies targeting MSM will fail to reach trans women and many of their cisgender men partners.
Collapse
|
4
|
Reducing HIV Risk Behaviors Among Black Women Living With and Without HIV/AIDS in the U.S.: A Systematic Review. AIDS Behav 2021; 25:732-747. [PMID: 32918639 DOI: 10.1007/s10461-020-03029-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/02/2020] [Indexed: 02/06/2023]
Abstract
This systematic review provides an examination of the status of HIV/AIDS prevention interventions for Black, heterosexual women in the U.S. from 2012 to 2019. Using PRISMA guidelines, 28 interventions were identified. Over half of the interventions were: conducted in the southern region of the U.S.; evaluated using a randomized controlled trial; focused on adults; used a group-based intervention delivery; were behaviorally focused and theoretically driven. None included biomedical strategies of PrEP, nPEP, and TasP. Few interventions included adolescent or aging Black women; none included their sex/romantic partners. Future studies dedicated to addressing the specific needs of subpopulations of Black, heterosexual women may provide opportunities to expand and/or tailor current and future HIV/AIDS prevention interventions, including offering participants with options to choose which, and the level of involvement, of their sex/romantic partner(s) in their sexual health decision-making. While strides to improve HIV prevention efforts with Black, heterosexual women have occurred, more is needed.
Collapse
|
5
|
How are transgender women acquiring HIV? Insights from phylogenetic transmission clusters in San Francisco. AIDS 2019; 33:2073-2079. [PMID: 31335804 DOI: 10.1097/qad.0000000000002318] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE We explored potential HIV transmission typologies that involve transgender women to obtain insights on sexual and needle-sharing networks as sources of HIV infection. DESIGN San Francisco residents diagnosed with HIV in care at public facilities who had available viral pol sequences from June 2001 to January 2016 were included in the analysis. METHODS Viral sequence data were matched to the San Francisco HIV/AIDS Case Registry to obtain demographic and risk classification information. Transmission clusters with at least two cases were identified by bootstrap values at least 90% and mean pairwise genetic distances 0.025 or less substitutions per site. RESULTS Transgender women represented 275 of 5200 patients; 86 were present in 70 clusters. Four typologies were hypothesized: first, transgender women in clusters with MSM; second, transgender women who inject drugs in clusters with cisgender women and men who inject drugs; third, multiple transgender women in clusters with one man; and fourth, multiple transgender women who do not inject drugs in clusters with men and cisgender women who inject drugs. CONCLUSION Transmission patterns of transgender women may stand apart from MSM epidemics. Transgender women clustered with people who inject drugs, and with men who have sex with transgender women and cisgender women. Aggregation of transgender women into the category of MSM may obscure understanding of how they acquire HIV and to whom they may transmit infection. Phylogenetic insights strengthen the case that HIV prevention programs for MSM may not be applicable to transgender women or their partners.
Collapse
|
6
|
Jemal A. Transformative Consciousness of Health Inequities: Oppression is a Virus and Critical Consciousness is the Antidote. JOURNAL OF HUMAN RIGHTS AND SOCIAL WORK 2018; 3:202-215. [PMID: 30687777 PMCID: PMC6345409 DOI: 10.1007/s41134-018-0061-8] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
Oppression has been identified as a fundamental cause of disease. Like a self-replicating virus, it infects systems from the biological to the political, contributing to personal (e.g., substance use, low self-esteem) and social (e.g., community violence, mass incarceration) dysfunction. Paulo Freire's critical consciousness (CC) is a philosophical, theoretical and practice-based framework that has been identified as an antidote to oppression. Critical consciousness constitutes an awareness of, and action against, institutional, historical, and systemic forces that limit or promote opportunities for certain groups. Although CC theory has been used to address inequity, very few scholars have attempted to conceptualize, operationalize and describe the development process of CC. In response to the conceptual inconsistencies widely noted in the CC literature, this paper presents a new construct, Transformative Consciousness (TC), composed of three domains: Awareness, Behavioral-Response, and Consequence, for each level of the socio-ecosystem. The staged process of TC development is also described. The theoretical framework of TC can be applied to various social issues, such as violence, mass incarceration, homelessness, HIV/STI infection, and substance use - all of which have tremendous implications for health and well-being as a human right. With further research, Transformative Consciousness may prove necessary to move persons in the direction of anti-oppressive, individual and collective action to overcome and dismantle oppression, creating a healthier and more just and liberated society.
Collapse
Affiliation(s)
- Alexis Jemal
- Silberman School of Social Work at Hunter College, 2180 3 Ave New York, NY 10035
| |
Collapse
|
7
|
Mirzazadeh A, Evans JL, Hahn JA, Jain J, Briceno A, Shiboski S, Lum PJ, Bentsen C, Davis G, Shriver K, Dimapasoc M, Stone M, Busch MP, Page K. Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement. AIDS Behav 2018; 22:1383-1394. [PMID: 29168067 PMCID: PMC6054135 DOI: 10.1007/s10461-017-1988-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
We measured HIV incidence rate, trend and risk factors in 564 HIV-negative young people (< 30 years) who inject drugs (PWID) in San Francisco between 2000 and 2014. HIV incidence was 0.93/100 person-years (PY; 95% CI 0.50, 1.73). Incidence varied between 0.62/100 PY in 2000-2002 and 1.06/100 PY in 2012-2014 (P for trend = 1.0). HIV incidence varied significantly (P < 0.01) by race/ethnicity: among Hispanics it was 8.19/100 PY (95% CI 3.41, 19.68), African-Americans 4.59/100 PY (95% CI 1.15, 18.37), and Whites 0.26/100 PY (95% CI 0.06, 1.03). Male participants who reported sex with men (MSM) had higher HIV incidence (2.63/100 PY; 95% CI 1.31, 5.25) compared to males who did not report MSM (0.50/100 PY; 95% CI 0.12, 1.99) (P = 0.01). Despite an overall stable HIV incidence trend, incidence was elevated among African-American and Hispanic PWID, and men who have sex with men. Addressing prevention needs in these key populations is critical for the goal of eliminating HIV transmission.
Collapse
Affiliation(s)
- Ali Mirzazadeh
- Department of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.
| | - Jennifer L Evans
- Department of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA
| | - Judith A Hahn
- Department of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA
- Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA
| | - Jennifer Jain
- Department of Global Public Health and Infectious Disease, School of Medicine, University of California, San Diego, San Diego, CA, USA
| | - Alya Briceno
- Department of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA
| | - Stephen Shiboski
- Division of HIV, Infectious Disease, and Global Medicine, Department of Medicine, University of California, San Francisco, 995 Potrero Avenue, Building 80, Ward 84, San Francisco, CA, 94110, USA
| | - Paula J Lum
- Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA
| | | | | | | | | | - Mars Stone
- Blood Systems Research Institute, San Francisco, CA, USA
| | - Michael P Busch
- Blood Systems Research Institute, San Francisco, CA, USA
- Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
| | - Kimberly Page
- Epidemiology, Biostatistics and Preventive Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
| |
Collapse
|
8
|
Exchange Sex and HIV Infection Among Women Who Inject Drugs-20 US Cities, 2009. J Acquir Immune Defic Syndr 2017; 75 Suppl 3:S333-S340. [PMID: 28604435 DOI: 10.1097/qai.0000000000001408] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Women who inject drugs and who also exchange sex are at increased risk for HIV infection, but data on this population in the United States remain sparse. METHODS This study assessed the prevalence of exchanging sex for money or drugs among women who inject drugs using data from the 2009 US National HIV Behavioral Surveillance (NHBS) system. Prevalence of being HIV-positive (testing positive in NHBS), HIV-positive-unaware (reporting being HIV-negative or unknown status but testing positive in NHBS), and risk behaviors and use of services were compared between women who did and did not exchange sex. The association between exchange sex and being HIV-positive-unaware of the infection was examined using multivariate Poisson models with robust standard errors. RESULTS Among 2305 women who inject drugs, 39% reported receiving things like money or drugs from ≥1 male partners in exchange for oral, vaginal, or anal sex in the previous 12 months. Women who exchanged sex were more likely to be unemployed, homeless, lack health insurance, have multiple condomless vaginal or anal sex partners, and receptively share syringes. In multivariate analysis, exchange sex was associated with being HIV-positive-unaware (adjusted prevalence ratio 1.97, 95% confidence intervals: 1.31 to 2.97). CONCLUSIONS Prevalence of exchange sex was high in this population. Women who exchange sex were more likely to be socially disadvantaged, report sexual and injection risk, and be HIV-positive-unaware. They represent an important group to reach with HIV prevention, testing, and care services.
Collapse
|
9
|
Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J 2017; 14:40. [PMID: 28662716 PMCID: PMC5492910 DOI: 10.1186/s12954-017-0166-x] [Citation(s) in RCA: 96] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2017] [Accepted: 06/05/2017] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Women who inject drugs (WWID) are at heightened risk for HIV due to biological, behavioral, and structural factors. Pre-exposure prophylaxis (PrEP) could aid in HIV prevention for WWID. However, little is known about WWID awareness of PrEP, which is a necessary step that must occur before PrEP uptake. We report factors associated with greater awareness among WWID to identify efficient means of awareness dissemination. METHODS Data from the 2015 National HIV Behavioral Surveillance (NHBS) system cycle on injection drug use collected in New York City (NYC) were used. Bivariable analyses, using chi-squared statistics, were conducted to examine correlates of awareness of PrEP with socio-demographic, behavioral, and health care variables. Multivariable logistic regression was used to estimate adjusted associations and determine differences in awareness of PrEP. RESULTS The analysis consisted of 118 WWID. Awareness of PrEP was relatively low (31%), and risk factors were high. In the last 12 months, almost two thirds (65%) reported condomless sex, approximately one third (31%) reported transactional sex, and one third (32%) reported sharing injection equipment. In multivariable logistic regression, increased PrEP awareness was associated with reported transactional sex (AOR 3.32, 95% CI 1.22-9.00) and having a conversation about HIV prevention at a syringe exchange program (SEP) (AOR 7.61, 95% CI 2.65-21.84). We did not find race, education, household income, age, binge drinking, or sexual identity to be significantly associated with PrEP awareness. CONCLUSIONS Large proportions of WWID were unaware of PrEP. These findings suggest that social networks (specifically sex work and SEP networks) are an efficient means for disseminating messaging about prevention materials such as PrEP. We recommend that SEP access increase, SEP processes be adopted in other health care settings, and WWID networks be utilized to increase PrEP awareness.
Collapse
Affiliation(s)
- Suzan M Walters
- Department of Sociology, State University of New York at Stony Brook, Stony Brook, NY, USA.
- , Stony Brook, New York, NY, 11794-4356, USA.
| | - Kathleen H Reilly
- New York City Department of Health and Mental Hygiene, New York City, NY, USA
| | - Alan Neaigus
- Department of Epidemiology Joseph L. Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Sarah Braunstein
- New York City Department of Health and Mental Hygiene, New York City, NY, USA
| |
Collapse
|
10
|
IAPAC Guidelines for Optimizing the HIV Care Continuum for Adults and Adolescents. J Int Assoc Provid AIDS Care 2015; 14 Suppl 1:S3-S34. [PMID: 26527218 DOI: 10.1177/2325957415613442] [Citation(s) in RCA: 80] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND An estimated 50% of people living with HIV (PLHIV) globally are unaware of their status. Among those who know their HIV status, many do not receive antiretroviral therapy (ART) in a timely manner, fail to remain engaged in care, or do not achieve sustained viral suppression. Barriers across the HIV care continuum prevent PLHIV from achieving the therapeutic and preventive effects of ART. METHODS A systematic literature search was conducted, and 6132 articles, including randomized controlled trials, observational studies with or without comparators, cross-sectional studies, and descriptive documents, met the inclusion criteria. Of these, 1047 articles were used to generate 36 recommendations to optimize the HIV care continuum for adults and adolescents. RECOMMENDATIONS Recommendations are provided for interventions to optimize the HIV care environment; increase HIV testing and linkage to care, treatment coverage, retention in care, and viral suppression; and monitor the HIV care continuum.
Collapse
|
11
|
Campbell LF, Wilmoth K, Mason M. Association of exposure to neighborhood drug activity, neurobehavioral traits, and marijuana use among at-risk African American females. Addict Behav 2015; 50:45-50. [PMID: 26101077 PMCID: PMC10176802 DOI: 10.1016/j.addbeh.2015.06.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2014] [Revised: 04/29/2015] [Accepted: 06/02/2015] [Indexed: 10/23/2022]
Abstract
INTRODUCTION Theories of relative deprivation suggest African Americans in disadvantaged communities are at increased risk for drug use. This increased risk may be due, in part, to exposure to drugs and drug subcultures. Given the significance of the prefrontal cortex (PFC) functioning in yielding behavior that is strategically guided rather than reactive to environmental demands, it is important to examine the relationship between PFC functioning, neighborhood drug activity and substance use among African Americans residing in high risk communities. METHODS A sample of 120 young adult African American females was recruited from high-risk neighborhoods. Each completed the modified version of the neighborhood environment scale, a neurobehavioral assessment designed to measure apathy, behavioral disinhibition and executive dysfunction, and provided a urine sample that was tested for the presence of psychoactive drugs. RESULTS Logistic regression analyses indicated that females with higher scores on behavioral disinhibition were 2.6 times more likely to test positive for marijuana (95%CI = 1.02, 6.57). Neither apathy nor executive dysfunction was related to marijuana use. No relationship emerged between neighborhood drug activity and marijuana use. CONCLUSIONS Among the neurobehavioral traits considered only behavioral disinhibition was associated with marijuana use, suggesting that different neurobehavioral domains may be uniquely related to marijuana use. For females living in high risk environments, the extent to which they are able to control impulses may provide some protection against marijuana use. Future studies focused on the moderating effects of behavioral disinhibition on the association of exposure to risk environments and marijuana use may prove beneficial. Further, the study adds to the small base of literature supporting the Frontal Systems Behavior Scale as a brief assessment to evaluate frontally-mediated neurobehavioral traits relevant to substance use. However, future studies aimed at examining the influence of neighborhood drug activity might benefit from more precise measures of exposure to neighborhood drug activity. More research to replicate and expand on the present findings is warranted.
Collapse
Affiliation(s)
- Leah Floyd Campbell
- Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States; Commonwealth Institute for Child & Family Studies, Virginia Commonwealth University, PO Box 980489, Richmond, VA 23298-0489, United States.
| | - Kristin Wilmoth
- Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9044, United States
| | - Michael Mason
- Commonwealth Institute for Child & Family Studies, Virginia Commonwealth University, PO Box 980489, Richmond, VA 23298-0489, United States
| |
Collapse
|
12
|
Zinski A, Westfall AO, Gardner LI, Giordano TP, Wilson TE, Drainoni ML, Keruly JC, Rodriguez AE, Malitz F, Batey DS, Mugavero MJ. The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes. Am J Public Health 2015; 105:2068-75. [PMID: 26270301 DOI: 10.2105/ajph.2015.302695] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES We explored the contribution of missed primary HIV care visits ("no-show") to observed disparities in virological failure (VF) among Black persons and persons with injection drug use (IDU) history. METHODS We used patient-level data from 6 academic clinics, before the Centers for Disease Control and Prevention and Health Resources and Services Administration Retention in Care intervention. We employed staged multivariable logistic regression and multivariable models stratified by no-show visit frequency to evaluate the association of sociodemographic factors with VF. We used multiple imputations to assign missing viral load values. RESULTS Among 10 053 patients (mean age = 46 years; 35% female; 64% Black; 15% with IDU history), 31% experienced VF. Although Black patients and patients with IDU history were significantly more likely to experience VF in initial analyses, race and IDU parameter estimates were attenuated after sequential addition of no-show frequency. In stratified models, race and IDU were not statistically significantly associated with VF at any no-show level. CONCLUSIONS Because missed clinic visits contributed to observed differences in viral load outcomes among Black and IDU patients, achieving an improved understanding of differential visit attendance is imperative to reducing disparities in HIV.
Collapse
Affiliation(s)
- Anne Zinski
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Andrew O Westfall
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Lytt I Gardner
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Thomas P Giordano
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Tracey E Wilson
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Mari-Lynn Drainoni
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Jeanne C Keruly
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Allan E Rodriguez
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Faye Malitz
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - D Scott Batey
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| | - Michael J Mugavero
- Anne Zinski, Andrew O. Westfall, D. Scott Batey, and Michael J. Mugavero are with the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham. Lytt I. Gardner is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Thomas P. Giordano is with the Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX. Tracey E. Wilson is with the Department of Community Health Sciences, State University of New York, Downstate Medical Center, Brooklyn, NY. Mari-Lynn Drainoni is with the Department of Health Policy and Management, Boston University School of Public Health, Boston, MA. Jeanne C. Keruly is with Johns Hopkins University, School of Medicine, Division of Infectious Diseases, Baltimore, MD. Allan E. Rodriguez is with the Division of Infectious Diseases, Miller School of Medicine, University of Miami, FL. Faye Malitz is with the HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, MD
| |
Collapse
|
13
|
Billings DW, Leaf SL, Spencer J, Crenshaw T, Brockington S, Dalal RS. A Randomized Trial to Evaluate the Efficacy of a Web-Based HIV Behavioral Intervention for High-Risk African American Women. AIDS Behav 2015; 19:1263-74. [PMID: 25616838 DOI: 10.1007/s10461-015-0999-9] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The aim of this study was to develop and test a cost-effective, scalable HIV behavioral intervention for African American women. Eighty-three African American women were recruited from a community health center and randomly assigned to either the web-based Safe Sistah program or to a delayed HIV education control condition. The primary outcome was self-reported condom use. Secondary measures assessed other aspects of the gender-focused training included in Safe Sistah. Participants completed self-report assessments prior to randomization, 1- and 4-months after their program experience. Across the entire study period, women in the experimental condition significantly increased their condom use relative to controls (F = 5.126, p = 0.027). Significant effects were also found for sexual communication, sex refusal, condom use after alcohol consumption, and HIV prevention knowledge. These findings indicate that this web-based program could be an important component in reducing the HIV disparities among African American women.
Collapse
Affiliation(s)
- Douglas W Billings
- ISA Associates, Inc., 201 North Union Street, Suite 330, Alexandria, VA, 22314, USA,
| | | | | | | | | | | |
Collapse
|
14
|
Cepeda A, Nowotny KM, Valdez A. Trajectories of Aging Long-Term Mexican American Heroin Injectors: The "Maturing Out" Paradox. J Aging Health 2015; 28:19-39. [PMID: 25953814 DOI: 10.1177/0898264315585503] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVE To examine the applicability of the "maturing out" theory to a sample of aging Mexican American men who are long-term heroin injectors. METHOD Ethnographic data were collected as part of a cross-sectional study of aging Mexican American heroin users in Houston with 20 current heroin users. RESULTS Findings indicate that dysfunctions that emerge in the heroin lifestyle lead not to cessation but rather to "maturing in," a specific process of social readjustment that returns the heroin user to a stable maintenance pattern of use instead of a recovery phase. This process of paradoxical maturing out can be attributed to the unconditional social support provided to the heroin user by family, peers, and the tecato subculture embedded in Mexican American communities. DISCUSSION Results highlight the implications for the intersection of heroin-related conditions, natural age-related impairments, and cognitive functioning that make this population increasingly susceptible to adverse health consequences.
Collapse
Affiliation(s)
- Alice Cepeda
- University of Southern California, Los Angeles, USA
| | | | | |
Collapse
|
15
|
Broz D, Pham H, Spiller M, Wejnert C, Le B, Neaigus A, Paz-Bailey G. Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009. AIDS Behav 2014; 18 Suppl 3:284-96. [PMID: 24242754 DOI: 10.1007/s10461-013-0660-4] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
This study compared HIV sero-prevalence and risk behaviors between younger and older injecting drug users (IDUs). IDUs aged ≥18 years were interviewed for the 2009 National HIV Behavioral Surveillance System. Using GEE regression, we assessed characteristics of younger (18-29 years) and older (≥30 years) IDUs, and factors associated with past 12-month receptive syringe sharing and unprotected sex (vaginal/anal). Of 10,090 participants, 10 % were younger. HIV sero-prevalence was lower among younger than older IDUs (4 vs. 10 %, p = 0.001). Younger IDUs were more likely (p ≤ 0.002) to be non-black race/ethnicity, report higher household income, homelessness, being arrested and to engage in receptive syringe sharing and unprotected sex. In multivariable models, age remained associated (p < 0.001) with receptive syringe sharing (aPR = 1.14, 95 % CI1.07-1.22) and unprotected sex (aPR = 1.10, 95 % CI1.06-1.14). Although younger IDUs had lower HIV prevalence, their behaviors place them at increased risk of HIV infection and could lead to a rapid spread in this susceptible population.
Collapse
Affiliation(s)
- Dita Broz
- Behavioral and Clinical Surveillance Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS-E46, Atlanta, GA, 30333, USA,
| | | | | | | | | | | | | |
Collapse
|